Executive Summary
This snapshot reveals $2.9B in contract option exercises dominated by bullish signals (16/18) in IT services and security equipment, with Leidos securing the largest $1.1B SSA award and DHS/CBP driving 5 contracts totaling $473M.
Public companies like Leidos (LDOS), General Dynamics (GD), OSI Systems (OSIS), and Oracle (ORCL) benefit from multi-year revenue visibility through 2029+, though firm fixed price (FFP) structures pose execution risks on 12/18 awards. Unexercised options exceed $2B across the portfolio, signaling medium-term growth potential amid steady federal demand in health IT, border security, and medical logistics.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior Contract Option Exercises digest from March 18, 2026.
Investment Signals (4)
- Leidos dominates civilian and DHS IT with $1.13B awards (HIGH)▲
Leidos secures top two contracts ($1.06B SSA IT management + $67M CBP equipment maintenance), with $906M outlayed and $425M options, providing 80%+ revenue visibility through 2028.
- DHS/CBP fuels security and IT backlog growth ($473M total) (HIGH)▲
Five DHS awards to Rapiscan/OSIS ($186M portals), Smiths Detection ($77M rail systems), Steampunk ($75M HR IT), GD IT ($68M infrastructure), and Leidos total $473M with extensions to 2031+.
- VA health IT and supplies locked in through 2029 ($381M) (MEDIUM)▲
Oracle ($176M EHRM), Deloitte ($67M cybersecurity), and Medline duo ($138M prime vendor) deliver $381M obligated, with $784M/$185M/$185M option ceilings signaling sustained VA spending.
- HHS/NIH animal care and Medicare contracts stabilize revenue (MEDIUM)▲
$318M CMS to Wisconsin Physicians + $96M Charles River NIH award (options to $486M/$185M) highlight cost-plus structures reducing risk in health services through 2029.
Risk Flags (3)
- Execution [HIGH RISK]▼
FFP on 12/18 contracts ($2.2B value) exposes winners to cost overruns without reimbursement, especially on long-term awards to 2031 (e.g., Rapiscan, Life Science Logistics).
- Competitive [MEDIUM RISK]▼
Non-competed awards (4/18, $427M) to Leidos, Oracle, GD One Source indicate sole-source reliance, vulnerable to future rebids post-2026/2027 ends.
- Market [MEDIUM RISK]▼
Future-dated Medline VA awards ($138M Jan/Feb 2026) carry $0 outlay risk amid potential VA procurement shifts.
Opportunities (3)
- ◆
$2B+ unexercised options (e.g., Oracle $608M, Salient $151M, Leidos DHS $183M) across 14 contracts could double obligated value if exercised.
- ◆
DHS/CBP extensions to 2031+ on detection/maintenance contracts signal rising border security spend, favoring hardware/IT integrators.
- ◆
High outlays (avg 50%+ on $1.9B obligated) on 12 contracts indicate low execution risk and steady FCF generation.
Sector Themes (3)
- ◆
IT/ telecom awards dominate (NAICS 54151x) across SSA, VA, HUD, DHS, Education, with 70%+ to incumbents like Leidos/GD.
- ◆
Detection portals/rails (Rapiscan, Smiths) and maintenance (Leidos) total $341M through 2031, amid CBP priorities.
- ◆
Medline's back-to-back 2026 prime vendor orders signal predictable wholesaling demand.
Watch List (4)
- 👁
{"entity"=>"Leidos Holdings (LDOS)", "reason"=>"$1.13B awards represent 10%+ potential backlog add, with $425M options", "trigger"=>"Q1 2026 backlog confirmation >$30B"}
- 👁
{"entity"=>"OSI Systems (OSIS)", "reason"=>"$186M Rapiscan CBP portals (71% outlayed) extend to 2033 potential", "trigger"=>"DHS FY2027 border tech budget increase"}
- 👁
{"entity"=>"Oracle (ORCL)", "reason"=>"$176M VA EHRM (options to $784M) in non-competed health IT", "trigger"=>"Option exercise or VA EHR follow-on award"}
- 👁
{"entity"=>"Medline Industries", "reason"=>"$138M VA 2026 awards at $0 outlay signal repeat prime vendor risk/reward", "trigger"=>"2026 Q1 outlay commencement"}
Get daily alerts with 4 investment signals, 3 risk alerts, 3 opportunities and full AI analysis of all 18 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: Contract Option Exercises
🇺🇸 More from United States
View all →May 27, 2026
US Pre-Market SEC Filings Roundup — May 27, 2026
US Pre-Market SEC Filings Roundup
May 27, 2026
S&P 500 Technology Sector SEC Filings — May 27, 2026
S&P 500 Technology Sector SEC Filings
May 27, 2026
Orphan Drug Approvals — May 27, 2026
Orphan Drug Approvals
May 27, 2026
Big Pharma Approvals — May 27, 2026
Big Pharma Approvals